IMR Press / FBS / Volume 1 / Issue 1 / DOI: 10.2741/S27

Frontiers in Bioscience-Scholar (FBS) is published by IMR Press from Volume 13 Issue 1 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with Frontiers in Bioscience.

Current advances in identification of cancer biomarkers in saliva
Show Less
1 School of Dentistry and Dental Research Institute, University of California at Los Angeles, Los Angeles CA 90095, USA
2 Center for Molecular Biology of Oral Diseases, College of Dentistry, University of Illinois at Chicago, Chicago IL 60612
3 Jonsson Comprehensive Cancer Center, University of California at Los Angeles, Los Angeles CA 90095

*Author to whom correspondence should be addressed.

Academic Editor: Xiaofeng Zhou

Front. Biosci. (Schol Ed) 2009, 1(1), 296–303;
Published: 1 June 2009

Saliva samples from certain disease patients harbor a wide spectrum of proteins, mRNAs, DNAs and other molecules that may be associated with the disease phenotype. If successfully discovered and validated, these informative molecules may serve as biomarkers, leading to the use of non-invasive biofluid for detecting and monitoring the diseases. This article summarizes the current advances in searching for potential biomarkers in saliva for human cancers, especially head and neck/oral cancers. With the new molecular profiling technologies such as microarray and proteomics, we are expecting to reveal highly discriminatory genomic and proteomic targets that can best detect the disease status.

Back to top